Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia–reperfusion injury by strengthening the blood–brain barrier function and anti-thrombo-inflammatory property.

MLA

Chen, Chunyan, et al. “Platelet Glycoprotein Receptor Ib Blockade Ameliorates Experimental Cerebral Ischemia–reperfusion Injury by Strengthening the Blood–brain Barrier Function and Anti-Thrombo-Inflammatory Property.” Brain, Behavior & Immunity, vol. 69, Mar. 2018, pp. 255–63. EBSCOhost, https://doi.org/10.1016/j.bbi.2017.11.019.

APA

Chen, C., Li, T., Zhao, Y., Qian, Y., Li, X., Dai, X., Huang, D., Pan, T., & Zhou, L. (2018). Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia–reperfusion injury by strengthening the blood–brain barrier function and anti-thrombo-inflammatory property. Brain, Behavior & Immunity, 69, 255–263. https://doi.org/10.1016/j.bbi.2017.11.019

Chicago

Chen, Chunyan, Tingting Li, Yuchen Zhao, Yinfeng Qian, Xiaoyi Li, Xiangrong Dai, Dake Huang, Tianzhong Pan, and Lanlan Zhou. 2018. “Platelet Glycoprotein Receptor Ib Blockade Ameliorates Experimental Cerebral Ischemia–reperfusion Injury by Strengthening the Blood–brain Barrier Function and Anti-Thrombo-Inflammatory Property.” Brain, Behavior & Immunity 69 (March): 255–63. doi:10.1016/j.bbi.2017.11.019.